Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 – Clinical Trial Not Allowed)

0
98

Funding Opportunity ID: 329642
Opportunity Number: RFA-GM-21-001
Opportunity Title: Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 – Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.859
Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Oct 30, 2020
Close Date: Jan 05, 2021
Last Updated Date: Oct 30, 2020
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding:
Expected Number of Awards:
Description: This Funding Opportunity Announcement (FOA) solicits applications to strengthen the regional technology transfer accelerator hubs for Institutional Development Award (IDeA) states. Accelerator hubs funded by the awards under this FOA are expected to develop, refine, and implement comprehensive programs for fostering biomedical entrepreneurship which will promote technology transfer, small business finance and management, and other business skills needed to move basic discoveries and technologies out of the lab into commercial products that improve patient care and enhance human health. Each Hub will serve a network of multiple institutional sites across the IDeA states in one of the four regions where the academic partners are located. The goals of this FOA are to: 1) build on regional technology transfer programs to further strengthen the capacity to bring scientific results from academic institutions into the market; 2) fund a pilot project program for product definition studies (e.g., feasibility studies, prototype development, proof-of-concept, and preclinical studies); 3) provide access to expertise and resources in areas required for early stage technology development; 4) provide skills development and hands-on experience in entrepreneurship; and 5) promote a sustainable culture of biomedical entrepreneurship within IDeA states. It is anticipated that the educational tools developed under this FOA will be licensed or sold to other institutions that wish to create accelerator hubs. Establishing public-private partnerships and securing additional non-federal funds will be critical for long-term success.
Version: 1





Visit the Official Webpage For More Details on Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 – Clinical Trial Not Allowed)

LEAVE A REPLY

Please enter your comment!
Please enter your name here